01Dose
| Human Dose | None established | Study |
| Ghk-Cu (Community) | 1–2 mg daily under the skin | Community |
| Kpv (Community, Oral) | 200–500 mcg, 1–2 times daily | Community |
| Per 1 Mg Of Blend | ~714 mcg GHK-Cu + ~286 mcg KPV | Community |
| At 1–2 Mg Ghk-Cu | You also get ~400–800 mcg KPV | Community |
Study amounts come from the sources below. Community amounts are what people report; nobody has tested them.
Mixing a vial
70 mg vial + 3 mL BAC water = ≈23.3 mg per mL
Bacteriostatic water. Fixed ratio: you can't change one part alone. 10 units ≈ 2.3 mg of blend.
Clean hands, alcohol on both rubber tops. Drip the water down the inside wall of the vial. Roll it gently until clear; do not shake. Date the vial and keep it in the fridge (2–8 °C), out of the light. Work out your syringe units →
Taken with
- Beauty Blend vs GLOW GLOW swaps KPV for BPC-157 and TB-500.
- Beauty Blend vs KLOW KLOW has all four: GHK-Cu, KPV, BPC-157 and TB-500.
- Beauty Blend vs separate vials Separate vials let you adjust GHK-Cu and KPV on their own. KPV was studied by mouth, not injection.
02Safety
- No safety data for the blend in people.
- User reports: stinging, redness or swelling at the injection site.
- User reports: blue-green tint near the injection site.
- User reports: mild nausea or headache.
- Allergic reaction, infection or contaminated product.
- Long-term effects of injected copper peptides are unknown.
- Avoid with Wilson's disease or other copper-handling disorders.
- Avoid with active cancer unless the oncology team agrees.
- Avoid in pregnancy or breastfeeding; no data.
- Known allergy to copper or any ingredient.
Common Less common Take care
Rules and status
- US FDA: not approved. We found no GHK-Cu or KPV product in Drugs@FDA.
- FDA compounding list (503A, Category 1, updated May 14 2026): GHK-Cu is listed except for injectable routes.
- No trial of the blend exists.
03How it works
Beauty Blend is the community name for GHK-Cu and KPV sold together. A common vial holds 50 mg GHK-Cu and 20 mg KPV, 70 mg in all. Every 1 mg of powder holds about 714 mcg GHK-Cu and 286 mcg KPV.
GHK-Cu is a natural copper peptide linked to collagen and skin repair. Its human evidence is on the skin: a 1994 gel trial in diabetic foot ulcers and small cream studies.
KPV is the last three amino acids of alpha-MSH. It turns down inflammation switches such as NF-kB and enters cells through the PepT1 transporter. It has no human trial.
The logic is to build collagen while keeping inflammation low. Users also say KPV softens the sting of GHK-Cu injections. Neither claim has been tested, and the pair has never been studied.
Watch the arithmetic. A community 1 to 2 mg of GHK-Cu also brings roughly 400 to 800 mcg of KPV by injection. Injected KPV has no human data.
- 01GHK-Cu
Signals skin cells to rebuild collagen.
- 02KPV
Turns down NF-kB, a main inflammation switch.
- 03Repair, less irritation
Rebuilding continues while redness calms.
- 04Calmer, firmer skin
The effect people use it for.
- GHK-Cu part
- Delivers copper and is linked to collagen, remodeling and wound repair in skin cells.
- KPV part
- Turns down NF-kB and MAP kinase inflammation signals once inside the cell.
- Why pair them
- Rebuilding and calming run side by side in wound repair. The blend aims at both, but the idea is untested.
04Evidence
| Finding | Tested in | Strength |
|---|---|---|
| Diabetic ulcersGHK-Cu gel closed ulcers a median 98.5% versus 60.8% with plain gel in 1994. | People | |
| Aged skinGHK-Cu creams are reported to tighten skin. The studies are small. | People | |
| Gut inflammationKPV eased two colitis models when given by mouth. | Animals | |
| Inflammation signalsKPV cut inflammatory signals in human gut cells in dishes. | Cells | |
| GermsKPV slowed Staph and Candida growth in dishes. | Cells |
05Our take
Beauty Blend is the simplest blend on the site: a collagen signal and an inflammation brake. Each part has a believable story.
What is known is GHK-Cu on the skin and KPV in lab and colitis work. Neither has human injection data, and the mix has never been tested.
What is missing is any evidence that KPV does what users say it does for GHK-Cu sting. It is a neat idea waiting for a test.
06What users say
Reports from users. Not tested.
- One draw Collagen signal and inflammation brake in one injection.
- Injection sting GHK-Cu can burn, redden or welt at the site.
- Skin look Texture and redness are the changes most mentioned.
- Slow change Skin changes take weeks to judge.
- Simple ratio Two parts are easier to track than GLOW or KLOW.
07FAQ
What is in it?
A common 70 mg vial: 50 mg GHK-Cu and 20 mg KPV.
How is it different from GLOW and KLOW?
No BPC-157 or TB-500. It is only the skin and inflammation parts.
Why add KPV to GHK-Cu?
GHK-Cu drives rebuilding; KPV calms inflammation that can slow it. Users also say it softens the sting.
How much is 10 units?
With 3 mL water, about 2.3 mg of blend: roughly 1.7 mg GHK-Cu and 670 mcg KPV.
Has it been tested in people?
No. GHK-Cu has skin gel data, KPV has none. See the Evidence section.
Does it work better than GHK-Cu alone?
Unknown. No study has compared the blend with either part.
Related peptides
GHK-CuKPVGLOW (BPC-157 + TB-500 + GHK-Cu blend)KLOW (GHK-Cu + KPV + BPC-157 + TB-500 blend)
08Sources
- Mulder GD et al. Wound Repair Regen 1994 (GHK-Cu gel in diabetic ulcers), PMID 17147644
- Pickart L et al. Biomed Res Int 2014 (GHK and gene activity), PMID 25302294
- Mateescu DM et al. Pharmaceutics 2026 (GHK-Cu evidence review), PMID 42797253
- Dalmasso G et al. Gastroenterology 2008 (KPV uptake by PepT1, anti-inflammatory action), PMID 18061177
- Kannengiesser K et al. Inflamm Bowel Dis 2008 (KPV in two colitis models), PMID 18092346
- Cutuli M et al. J Leukoc Biol 2000 (alpha-MSH peptides vs Staph and Candida), PMID 10670585
- Composition arithmetic: 50 / 70 mg = 714 mcg per mg; 20 / 70 mg = 286 mcg per mg
- Same sources as the GHK-Cu and KPV pages